These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

969 related articles for article (PubMed ID: 27882473)

  • 21. Expanding and converting regulatory T cells: a horizon for immunotherapy.
    Khattar M; Chen W; Stepkowski SM
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
    Terry LV; Oo YH
    Front Immunol; 2020; 11():565518. PubMed ID: 33072105
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Lawless OJ; Bellanti JA; Brown ML; Sandberg K; Umans JG; Zhou L; Chen W; Wang J; Wang K; Zheng SG
    Allergy Asthma Proc; 2018 Mar; 39(2):143-152. PubMed ID: 29490770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of regulatory T Cells in autoimmune orchitis.
    Jacobo P
    Andrologia; 2018 Dec; 50(11):e13092. PubMed ID: 30569653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splicing factor SRSF1 controls autoimmune-related molecular pathways in regulatory T cells distinct from FoxP3.
    Cassidy MF; Herbert ZT; Moulton VR
    Mol Immunol; 2022 Dec; 152():140-152. PubMed ID: 36368121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.
    Qiu R; Zhou L; Ma Y; Zhou L; Liang T; Shi L; Long J; Yuan D
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):52-70. PubMed ID: 30449014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?
    Lan Q; Fan H; Quesniaux V; Ryffel B; Liu Z; Zheng SG
    J Mol Cell Biol; 2012 Feb; 4(1):22-8. PubMed ID: 22107826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FoxP3 in T
    Deng G; Song X; Greene MI
    Clin Exp Immunol; 2020 Mar; 199(3):255-262. PubMed ID: 31386175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells.
    Delemarre EM; van den Broek T; Mijnheer G; Meerding J; Wehrens EJ; Olek S; Boes M; van Herwijnen MJ; Broere F; van Royen A; Wulffraat NM; Prakken BJ; Spierings E; van Wijk F
    Blood; 2016 Jan; 127(1):91-101. PubMed ID: 26480932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stabilizing human regulatory T cells for tolerance inducing immunotherapy.
    He X; Koenen HJ; Slaats JH; Joosten I
    Immunotherapy; 2017 Aug; 9(9):735-751. PubMed ID: 28771099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression.
    Zhang Y; Yao YM; Huang LF; Dong N; Yu Y; Sheng ZY
    J Interferon Cytokine Res; 2011 Feb; 31(2):249-57. PubMed ID: 21087077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.
    Alexander T; Sattler A; Templin L; Kohler S; Groß C; Meisel A; Sawitzki B; Burmester GR; Arnold R; Radbruch A; Thiel A; Hiepe F
    Ann Rheum Dis; 2013 Sep; 72(9):1549-58. PubMed ID: 23264341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia.
    Nishimoto T; Kuwana M
    Semin Hematol; 2013 Jan; 50 Suppl 1():S43-9. PubMed ID: 23664516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease.
    Hadaschik EN; Wei X; Leiss H; Heckmann B; Niederreiter B; Steiner G; Ulrich W; Enk AH; Smolen JS; Stummvoll GH
    Arthritis Res Ther; 2015 Feb; 17(1):35. PubMed ID: 25890083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revisiting regulatory T cells in type 1 diabetes.
    Zhang Y; Bandala-Sanchez E; Harrison LC
    Curr Opin Endocrinol Diabetes Obes; 2012 Aug; 19(4):271-8. PubMed ID: 22732485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
    Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
    Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ring finger protein 31-mediated atypical ubiquitination stabilizes forkhead box P3 and thereby stimulates regulatory T-cell function.
    Zhu F; Yi G; Liu X; Zhu F; Zhao A; Wang A; Zhu R; Chen Z; Zhao B; Fang S; Yu X; Lin R; Liang R; Li D; Zhao W; Zhang Z; Guo W; Zhang S; Ge S; Fan X; Zhao G; Li B
    J Biol Chem; 2018 Dec; 293(52):20099-20111. PubMed ID: 30389786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus.
    Lyssuk EY; Torgashina AV; Soloviev SK; Nassonov EL; Bykovskaia SN
    Adv Exp Med Biol; 2007; 601():113-9. PubMed ID: 17712998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581.
    Banham AH; Pulford K
    Expert Opin Ther Pat; 2009 Jul; 19(7):1023-8. PubMed ID: 19456276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory T Cells in SLE: Biology and Use in Treatment.
    Giang S; La Cava A
    Curr Rheumatol Rep; 2016 Nov; 18(11):67. PubMed ID: 27704250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.